Insider Transactions Reported by 11 Insiders of Lantern Pharma Inc.

Symbol
LTRN on Nasdaq
Location
Dallas, TX

Insiders trading volume in the past year

Lantern Pharma Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Leslie W. Kreis 10%+ Owner $3.34M -$500K -13% 13 Jun 2025
Aaron G.L. Fletcher 10%+ Owner $3.34M -$500K -13% 13 Jun 2025
D. JEFFREY KEYSER Director $0 19 Sep 2025
David S. Silberstein Director 19 Sep 2025
PANNA SHARMA President & CEO, Director 19 Sep 2025
Vijay Chandru Director 19 Sep 2025
David R. Margrave Chief Financial Officer 18 Dec 2025
FRANKLYN G. PRENDERGAST Director 04 Nov 2021
Kishor G. Bhatia Chief Scientific Officer 18 Dec 2025
Lee T. Schalop Director 19 Aug 2025
Maria-Luisa Maccecchini Director 15 Jul 2024

Recent Insider Transactions by Companies or Individuals for Lantern Pharma Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.